138 related articles for article (PubMed ID: 26150103)
1. Amphotericin B but not itraconazole is able to prevent grain formation in experimental Madurella mycetomatis mycetoma in mice.
van de Sande WW; van Vianen W; ten Kate M; Fahal A; Bakker-Woudenberg I
Br J Dermatol; 2015 Dec; 173(6):1561-2. PubMed ID: 26150103
[No Abstract] [Full Text] [Related]
2. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.
Ahmed AO; van de Sande WW; van Vianen W; van Belkum A; Fahal AH; Verbrugh HA; Bakker-Woudenberg IA
Antimicrob Agents Chemother; 2004 Jul; 48(7):2742-6. PubMed ID: 15215141
[TBL] [Abstract][Full Text] [Related]
3. Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatis.
Eadie K; Parel F; Helvert-van Poppel M; Fahal A; van de Sande W
Trop Med Int Health; 2017 Jun; 22(6):696-702. PubMed ID: 28342219
[TBL] [Abstract][Full Text] [Related]
4. Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole.
van de Sande WW; de Kat J; Coppens J; Ahmed AO; Fahal A; Verbrugh H; van Belkum A
Microbes Infect; 2007 Jul; 9(9):1114-23. PubMed ID: 17644456
[TBL] [Abstract][Full Text] [Related]
5. The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo.
Konings M; Eadie K; Strepis N; Nyuykonge B; Fahal AH; Verbon A; van de Sande WWJ
Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37960934
[TBL] [Abstract][Full Text] [Related]
6. In vitro antifungal activity of isavuconazole against Madurella mycetomatis.
Kloezen W; Meis JF; Curfs-Breuker I; Fahal AH; van de Sande WW
Antimicrob Agents Chemother; 2012 Nov; 56(11):6054-6. PubMed ID: 22964246
[TBL] [Abstract][Full Text] [Related]
7. Amphotericin B and terbinafine but not the azoles prolong survival in Galleria mellonella larvae infected with Madurella mycetomatis.
Kloezen W; Parel F; Brüggemann R; Asouit K; Helvert-van Poppel M; Fahal A; Mouton J; van de Sande W
Med Mycol; 2018 Jun; 56(4):469-478. PubMed ID: 28992315
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella.
Lim W; Konings M; Parel F; Eadie K; Strepis N; Fahal A; Verbon A; van de Sande WWJ
Med Mycol; 2022 Feb; 60(2):. PubMed ID: 35064672
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of an
Abd Algaffar SO; Verbon A; van de Sande WWJ; Khalid SA
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318015
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma.
Nyuykonge B; Siddig EE; Mhmoud NA; Nyaoke BA; Zijlstra EE; Verbon A; Bakhiet S; Fahal AH; van de Sande WWJ
Mycoses; 2022 Dec; 65(12):1170-1178. PubMed ID: 36005544
[TBL] [Abstract][Full Text] [Related]
11. A Madurella mycetomatis Grain Model in Galleria mellonella Larvae.
Kloezen W; van Helvert-van Poppel M; Fahal AH; van de Sande WW
PLoS Negl Trop Dis; 2015; 9(7):e0003926. PubMed ID: 26173126
[TBL] [Abstract][Full Text] [Related]
12. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden.
Ahmed AO; van Leeuwen W; Fahal A; van de Sande W; Verbrugh H; van Belkum A
Lancet Infect Dis; 2004 Sep; 4(9):566-74. PubMed ID: 15336224
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for
Nyuykonge B; van Amelsvoort L; Eadie K; Fahal AH; Verbon A; van de Sande W
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0043321. PubMed ID: 34181477
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine.
van Belkum A; Fahal AH; van de Sande WW
Antimicrob Agents Chemother; 2011 Apr; 55(4):1771-3. PubMed ID: 21263050
[TBL] [Abstract][Full Text] [Related]
15. A Falciformispora senegalensis grain model in Galleria mellonella larvae.
Ma J; Konings M; Verbon A; van de Sande WWJ
Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37451815
[TBL] [Abstract][Full Text] [Related]
16. Complete Genome Sequence of the Itraconazole Decreased Susceptible Madurella fahalii Type-Strain CBS 129176.
Konings M; Gerrits van den Ende B; Raats MWJ; Fahal AH; van de Sande WWJ; Hagen F
Mycopathologia; 2024 Jan; 189(1):6. PubMed ID: 38231295
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and molecular characterization of Madurella pseudomycetomatis sp. nov., a novel opportunistic fungus possibly causing black-grain mycetoma.
Yan J; Deng J; Zhou CJ; Zhong BY; Hao F
J Clin Microbiol; 2010 Jan; 48(1):251-7. PubMed ID: 19923486
[TBL] [Abstract][Full Text] [Related]
18. The synthetic synergistic cinnamon oil CIN-102 is active against Madurella mycetomatis, the most common causative agent of mycetoma.
Konings M; Eadie K; Lim W; Fahal AH; Mouton J; Tesse N; van de Sande WWJ
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009488. PubMed ID: 34106933
[TBL] [Abstract][Full Text] [Related]
19. Challenges in culture-negative cases of Madurella mycetomatis: A case report re-accentuating PCR as an essential diagnostic tool.
K S; Das S; Pandhi D; Rai G; Ansari MA; Gupta C; Haque S; Dar SA
J Mycol Med; 2017 Dec; 27(4):577-581. PubMed ID: 29102309
[TBL] [Abstract][Full Text] [Related]
20. Eumycotic mycetoma caused by Madurella mycetomatis successfully treated with antifungals, surgery, and topical negative pressure therapy.
Estrada-Chavez GE; Vega-Memije ME; Arenas R; Chavez-Lopez G; Estrada-Castañon R; Fernandez R; Hay R; Dominguez-Cherit J
Int J Dermatol; 2009 Apr; 48(4):401-3. PubMed ID: 19335427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
